DrugPatentWatch Database Preview
Details for Patent: 10,034,877
» See Plans and Pricing
Which drugs does patent 10,034,877 protect, and when does it expire?
Patent 10,034,877 protects TRADJENTA and is included in one NDA.
This patent has forty patent family members in twenty-three countries.
Summary for Patent: 10,034,877
| Title: | Treatment for diabetes in patients inappropriate for metformin therapy |
| Abstract: | The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication against metformin. |
| Inventor(s): | Dugi; Klaus (London, GB), Graefe-Mody; Eva Ulrike (Ingelheim am Rhein, DE), Harper; Ruth (Reading, GB), Woerle; Hans-Juergen (Munich, DE) |
| Assignee: | Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
| Application Number: | 15/287,228 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,034,877
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | TRADJENTA | linagliptin | TABLET;ORAL | 201280-001 | May 2, 2011 | RX | Yes | Yes | Start Trial | Start Trial | TREATMENT OF TYPE 2 DIABETES MELLITUS IN A PATIENT WITH RENAL IMPAIRMENT AND FOR WHOM METFORMIN THERAPY IS INAPPROPRIATE BY ADMINISTERING LINAGLIPTIN WITHOUT DOSE ADJUSTMENT | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,034,877
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 072920 | Start Trial | |||
| Australia | 2009279085 | Start Trial | |||
| Canada | 2732803 | Start Trial | |||
| Chile | 2011000259 | Start Trial | |||
| China | 102105145 | Start Trial | |||
| China | 103550219 | Start Trial | |||
| China | 105126105 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
